Page 65 - Bsx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bsx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bsx Today - Breaking & Trending Today

Moors & Cabot Inc. Reduces Stake in Boston Scientific Co. (NYSE:BSX)

Moors & Cabot Inc. lessened its stake in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 2.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 32,131 shares of the medical equipment provider’s stock after selling 777 shares during the quarter. Moors & Cabot Inc.’s holdings in Boston Scientific were worth […] ....

United States , Wendy Carruthers , Jeffreyb Mirviss , Stifel Nicolaus , Boston Scientific Corp , Deutsche Bank Aktiengesellschaft , Moors Cabot Inc , Family Office , Boston Scientific , Holdings Channel , Baldwin Brothers , Acadian Asset Management , Securities Exchange Commission , Hazlett Burt Watson Inc , Royal Bank , Boston Scientific Co , Get Rating , Asset Management , Exchange Commission , Visit Holdingschannel , Boston Scientific Daily , Nyse Bsx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Boston Scientific (NYSE:BSX) Updates FY23 Earnings Guidance

Boston Scientific (NYSE:BSX – Get Rating) updated its FY23 earnings guidance on Wednesday. The company provided earnings per share guidance of $1.90-1.96 for the period, compared to the consensus earnings per share estimate of $1.91. The company issued revenue guidance of ~$13.76-14.01 billion, compared to the consensus revenue estimate of $13.54 billion. Boston Scientific also […] ....

United States , Stifel Nicolaus , Boston Scientific , United Capital Financial Advisers , Campbell Co Investment Adviser , Morgan Stanley , Virtu Financial , Laurel Wealth Advisors Inc , Sequoia Financial Advisors , Boston Scientific Corp , Get Rating , Truist Financial , Capital Financial Advisers , Financial Advisors , Laurel Wealth Advisors , Boston Scientific Daily , Nyse Bsx ,

Boston Scientific (NYSE:BSX) Updates Q2 2023 Earnings Guidance

Boston Scientific (NYSE:BSX – Get Rating) updated its second quarter 2023 earnings guidance on Thursday. The company provided EPS guidance of $0.48-$0.50 for the period, compared to the consensus EPS estimate of $0.48. The company issued revenue guidance of $3.46 billion-$3.52 billion, compared to the consensus revenue estimate of $3.44 billion. Boston Scientific also updated […] ....

United States , John Bradley Sorenson , Stifel Nicolaus , Boston Scientific Company Profile , Arrowstreet Capital Limited Partnership , Boston Scientific Corp , Securities Exchange Commission , Boston Scientific , Moneta Group Investment Advisors , Norges Bank , Get Rating , Truist Financial , Bradley Sorenson , Exchange Commission , Group Investment Advisors , Capital Management , Capital Limited Partnership , Zentral Genossenschafts Bank Frankfurt , Boston Scientific Daily , Nyse Bsx ,

Retirement Systems of Alabama Sells 963,653 Shares of Boston Scientific Co. (NYSE:BSX)

Retirement Systems of Alabama trimmed its stake in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 67.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 458,857 shares of the medical equipment provider’s stock after selling 963,653 shares during the […] ....

United States , Raymond James , Danielj Brennan , Baldwin Brothers , Hazlett Burt Watson Inc , Family Office , Boston Scientific , Boston Scientific Co , Acadian Asset Management , Boston Scientific Corp , Jpmorgan Chase Co , Deutsche Bank Aktiengesellschaft , Securities Exchange Commission , Retirement Systems , Get Rating , Asset Management , Exchange Commission , Bank Aktiengesellschaft , Boston Scientific Daily , Nyse Bsx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Royal Bank of Canada Increases Boston Scientific (NYSE:BSX) Price Target to $56.00

Boston Scientific (NYSE:BSX – Get Rating) had its target price upped by stock analysts at Royal Bank of Canada from $53.00 to $56.00 in a report issued on Thursday, The Fly reports. Royal Bank of Canada’s target price would indicate a potential upside of 8.91% from the company’s current price. A number of other research […] ....

United States , Danielj Brennan , Wendy Carruthers , Boston Scientific , Boston Scientific Corp , Royal Bank , Geode Capital Management , Moneta Group Investment Advisors , Vanguard Group Inc , Artisan Partners Limited Partnership , Securities Exchange Commission , Get Rating , Truist Financial , Exchange Commission , Capital Management , Zentral Genossenschafts Bank Frankfurt , Partners Limited Partnership , Group Investment Advisors , Boston Scientific Daily , Nyse Bsx , Boost Price Target , Royal Bank Of Canada ,